These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10487493)

  • 41. Acyl chain and headgroup specificity of human plasma phospholipid transfer protein.
    Huuskonen J; Olkkonen VM; Jauhiainen M; Metso J; Somerharju P; Ehnholm C
    Biochim Biophys Acta; 1996 Oct; 1303(3):207-14. PubMed ID: 8908155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive.
    Oka T; Kujiraoka T; Ito M; Egashira T; Takahashi S; Nanjee MN; Miller NE; Metso J; Olkkonen VM; Ehnholm C; Jauhiainen M; Hattori H
    J Lipid Res; 2000 Oct; 41(10):1651-7. PubMed ID: 11013307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
    Rao R; Albers JJ; Wolfbauer G; Pownall HJ
    Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural and functional determinants of human plasma phospholipid transfer protein activity as revealed by site-directed mutagenesis of charged amino acids.
    Ponsin G; Qu SJ; Fan HZ; Pownall HJ
    Biochemistry; 2003 Apr; 42(15):4444-51. PubMed ID: 12693940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of phospholipid transfer protein (PLTP) on HDL metabolism.
    Huuskonen J; Olkkonen VM; Jauhiainen M; Ehnholm C
    Atherosclerosis; 2001 Apr; 155(2):269-81. PubMed ID: 11254896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein.
    Post SM; de Crom R; van Haperen R; van Tol A; Princen HM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):892-7. PubMed ID: 12649089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of human plasma phospholipid transfer protein mass and activity.
    Jauhiainen M; Ehnholm C
    Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins.
    Wolfbauer G; Albers JJ; Oram JF
    Biochim Biophys Acta; 1999 Jul; 1439(1):65-76. PubMed ID: 10395966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin.
    Lagrost L; Athias A; Lemort N; Richard JL; Desrumaux C; Châtenet-Duchêne L; Courtois M; Farnier M; Jacotot B; Braschi S; Gambert P
    Atherosclerosis; 1999 Apr; 143(2):415-25. PubMed ID: 10217372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.
    Colhoun HM; Scheek LM; Rubens MB; Van Gent T; Underwood SR; Fuller JH; Van Tol A
    Diabetes; 2001 Mar; 50(3):652-9. PubMed ID: 11246887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
    O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
    Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.
    Bruce C; Chouinard RA; Tall AR
    Annu Rev Nutr; 1998; 18():297-330. PubMed ID: 9706227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA.
    Siggins S; Kärkkäinen M; Tenhunen J; Metso J; Tahvanainen E; Olkkonen VM; Jauhiainen M; Ehnholm C
    J Lipid Res; 2004 Feb; 45(2):387-95. PubMed ID: 14617737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I.
    Jauhiainen M; Huuskonen J; Baumann M; Metso J; Oka T; Egashira T; Hattori H; Olkkonen VM; Ehnholm C
    J Lipid Res; 1999 Apr; 40(4):654-64. PubMed ID: 10191289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease.
    Schlitt A; Bickel C; Thumma P; Blankenberg S; Rupprecht HJ; Meyer J; Jiang XC
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1857-62. PubMed ID: 12947020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
    Dullaart RP; van Tol A
    Diabet Med; 2001 Jun; 18(6):509-13. PubMed ID: 11472472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).
    Cheung MC; Sibley SD; Palmer JP; Oram JF; Brunzell JD
    J Lipid Res; 2003 Aug; 44(8):1552-8. PubMed ID: 12777470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
    Vergeer M; Boekholdt SM; Sandhu MS; Ricketts SL; Wareham NJ; Brown MJ; de Faire U; Leander K; Gigante B; Kavousi M; Hofman A; Uitterlinden AG; van Duijn CM; Witteman JC; Jukema JW; Schadt EE; van der Schoot E; Kastelein JJ; Khaw KT; Dullaart RP; van Tol A; Trip MD; Dallinga-Thie GM
    Circulation; 2010 Aug; 122(5):470-7. PubMed ID: 20644014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
    Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.